AI-Powered Precision Medicine
ProxAI is a biotech company specializing in the development of first-in-class protein therapeutics leveraging artificial intelligence to address hard-to-drug diseases. ProxAI has developed a high-throughput platform that enables the screening of thousands of AI-designed protein binder sequences in a single, one-shot cell-based assay.
Our Unique Platform
Discover how ProxAI leverages AI-driven design and cellular screening to accelerate peptide therapeutic development with precision and efficiency.
Step 1: AI-Driven Design of Peptide
We initiate by applying advanced AI algorithms to design highly specific peptide binders tailored to target molecules.
Step 2: High-Throughput Screening
Next, peptides undergo rapid screening in physiologically relevant cellular environments to validate binding and efficacy.
Step 3: Optimized Peptide Selection
Finally, we analyze data to select the most promising peptide candidates, streamlining progression toward clinical development.
Our Talented Team Members
Jonathan Boulais, PhD.
Co-Founder, CEO
PhD in Cell Biology & Proteomics
Specialist in Protein-Protein Interactions
Vaccine designer @ GSK
Bioinformatician @ IRCM
Luc English, PhD. MBA GCP
Co-Founder, CSO
PhD in cell biology & immunology
MBA in Science and Engineering
Scientific director @ Logiag
Scientific Consultant @ Bioprevox Inc
Our Talented Advisors
François-Thomas Michaud, PhD.
Scientific & Business Advisor
CEO @ Feldan Therapeutics
BIOQuebec Board Member
Mika Guérard, PhD. MBA
Scientific & Business Advisor
Scientific advisor @ Neolys, EIR Telescope Pharma, Director – Drug Development OptiKira LLC, Koutif LLC, Anteros LLC, SuJanaBio LLC, SapVax LLC.
Jean-François Côté, PhD.
Scientific Advisor
President and Scientific Director @ IRCM
Full research professor @ Université de Montréal
Adjunct professor @ McGill University
Marina Massingham, MSc.
Scientific & Business Advisor
CEO @ Aifred Health
Co-founder of TeOra Health
MEDTEQ+ Board member
Lead Coach @ District 3 Bio Stream
Margaret Bywater-Ekegard
Scientific & Business Advisor
Co-founder of Inocucor Technologies
Co-founded & board member of Morphocell
Lead Coach @ District 3 Bio Stream
Contact Us !
Discover how ProxAI’s AI-driven platform accelerates drug discovery—subscribe for insights, request a demo, or connect with our experts to advance your research.equest a demo, or connect with our experts to advance your research.